Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,821,000 | 9,969,000 | 7,704,000 | 5,385,000 | 2,948,000 |
| Depreciation Amortization | 1,205,000 | 3,577,000 | 2,663,000 | 1,426,000 | 761,000 |
| Income taxes - deferred | 537,000 | 1,733,000 | 1,578,000 | 1,103,000 | 582,000 |
| Accounts receivable | N/A | 26,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 490,000 | N/A | N/A | N/A |
| Other Working Capital | -2,463,000 | -854,000 | -2,639,000 | -2,685,000 | -1,408,000 |
| Other Operating Activity | -193,000 | -874,000 | 184,000 | 1,034,000 | 424,000 |
| Operating Cash Flow | $1,907,000 | $14,067,000 | $9,490,000 | $6,263,000 | $3,307,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,365,000 | 12,631,000 | 12,821,000 | -3,016,000 | -319,000 |
| PPE Investments | -198,000 | -1,642,000 | -841,000 | -555,000 | -260,000 |
| Net Acquisitions | -589,000 | -26,666,000 | -26,666,000 | -499,000 | -413,000 |
| Purchase Of Investment | N/A | -124,000 | -483,000 | N/A | N/A |
| Sale Of Investment | N/A | 66,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -87,000 | -9,000 | N/A | -437,000 | -144,000 |
| Other Investing Activity | -87,000 | -21,000 | 0 | -437,000 | -144,000 |
| Investing Cash Flow | $491,000 | $-15,756,000 | $-15,169,000 | $-4,507,000 | $-1,136,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,718,000 | 2,610,000 | 12,258,000 | 5,181,000 | 4,234,000 |
| Debt Issued | N/A | 5,674,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -5,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 730,000 | N/A | N/A | N/A |
| Common Stock Repurchased | -2,829,000 | -343,000 | 438,000 | 307,000 | 368,000 |
| Dividend Paid | -5,352,000 | -4,550,000 | -4,520,000 | -4,516,000 | -4,580,000 |
| Other Financing Activity | -24,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-487,000 | $4,116,000 | $8,176,000 | $972,000 | $22,000 |
| Exchange Rate Effect | -56,000 | -2,000 | -5,000 | -64,000 | -21,000 |
| Beginning Cash Position | 5,319,000 | 2,894,000 | 2,894,000 | 2,894,000 | 2,894,000 |
| End Cash Position | 7,174,000 | 5,319,000 | 5,386,000 | 5,558,000 | 5,066,000 |
| Net Cash Flow | $1,855,000 | $2,425,000 | $2,492,000 | $2,664,000 | $2,172,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,907,000 | 14,067,000 | 9,490,000 | 6,263,000 | 3,307,000 |
| Capital Expenditure | -419,000 | -1,678,000 | -1,005,000 | -659,000 | -304,000 |
| Free Cash Flow | 1,488,000 | 12,389,000 | 8,485,000 | 5,604,000 | 3,003,000 |